Safety and Immunogenicity of Three V181 Dengue Vaccine Potencies in Adults (V181-003)
Clinical trial NCT05507450 · COMPLETED
Trial details
- NCT number
- NCT05507450
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-07
- Primary completion
- 2023-06-05
- Enrollment
- 1271
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.